Why AI keeps failing clinical trials | Daniel Lou × The End (Ep. 1) скачать в хорошем качестве

Why AI keeps failing clinical trials | Daniel Lou × The End (Ep. 1)

In an industry that confuses algorithmic sophistication with real progress, this conversation cuts straight to the point. For the first episode of The End podcast, Biorce CEO Pedro Coelho sits down with Daniel Lou, ex-McKinsey, ex-Roche, and founder of Revelo, a platform accelerating clinical trials from recruitment to regulatory endpoints. They discuss: • Why most AI solutions in clinical trials fail when regulators get involved • The mistakes pharma keeps repeating with technology adoption • How to design clinical trial protocols that work in the real world • What makes clinical trial tech companies succeed — or stall This is not a hype-driven AI conversation. It’s a grounded discussion about execution, incentives, and the uncomfortable truths shaping the future of clinical trials. ___________________________________________________________________ Biorce is a healthtech company focused on accelerating clinical trials, making them faster and more efficient. Aika is Biorce’s AI-powered platform the first AI-native solution designed to accelerate clinical trial setup and reduce risk by integrating protocol design, feasibility and regulatory planning. https://www.linkedin.com/company/biorce/ #TheEndPodcast #ClinicalTrials #Pharma #AI #DrugDevelopment #Biotech #HealthTech #Biorce